2Année·

Fast Track is being discussed for Anktiva in lung cancer. Now it's all happening fast.

attachment

$IBRX (-6,23 %)

7
3 Commentaires

image de profil
Just don't forget to take profits and sell off the hype before everyone else does with small biotech bets 💪🏼
•
1
•
image de profil
I intend to hold on for the long term. $IBRX is about to make history - in my opinion.
••
image de profil
2Année
@Vestin I don't want to spread conspiracy theories, but does it suit all interest groups that a solution will ever be found here?
•
2
•
Participez à la conversation